Subscribe to our Email Alerts

Island Pharmaceuticals
  • About Us
    • Island at a glance
    • Board
    • Key Management
    • Scientific Advisory Board
    • Collaborations
  • Science
    • About ISLA-101
    • Scientific Publications
    • Drug repurposing and benefits
    • Disease and drug terms explained
  • Investor Centre
    • Investor Welcome
      • Clinical programme
    • ASX Announcements
    • Presentations
    • Prospectus
    • Financial Reports
    • Share Price Information
    • Shareholder Services
    • Investor Fact Sheet
    • Corporate Governance
    • Corporate Directory
    • International Investors
    • Research Coverage
    • AGM
  • Media
    • News
    • IslandWatch Newsletter
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Media
Media > News
  • News
  • IslandWatch Newsletter

News

Filter by Year:2025 2024 2023 2022 2021 2020 
6-Nov-2023
Island Pharmaceuticals gains ISLA-101 study ethics approval for dengue fever
6-Nov-2023
Island Pharma welcomes green light for ISLA-101 clinical study
1-Nov-2023
Island Pharmaceuticals granted Australian patent for ISLA-101
27-Sep-2023
Island Pharmaceuticals CEO and Managing Director Dr David Foster on ausbiz
26-Sep-2023
Island Pharma gearing up to start ISLA-101 trial for dengue fever
25-Sep-2023
Island Pharmaceuticals readies for ISLA-101 trial for dengue fever
13-Sep-2023
Island Pharmaceuticals secures key US patent for dengue fever treatment
7-Jul-2023
$US1.3m grant for dengue fever study
6-Jul-2023
Island Pharmaceuticals secures US grant funding to support clinical development of dengue fever candidate
24-May-2023
Island Pharmaceuticals sees tremendous opportunity for mosquito-borne virus program
  • Previous 
  • 1
  • 2
  • 3
  •  Next

NOTICE

It has come to the company's attention that unauthorised individuals may be falsely claiming to represent Island Pharmaceuticals Limited in employment offers and recruitment communications. Please be advised that all legitimate employment opportunities are advertised through official company channels, the company's social media channels and via authorised recruitment partners.

Island Pharmaceuticals Limited will never request payment, personal financial information, or conduct interviews via unofficial platforms. If you receive a suspicious message or offer, please report it to us immediately at henry.jordan@sdir.com.au

Your safety and security are important to us.

Kind regards,
Island Pharmaceuticals Limited

Quick Links

Contact Us

Island Pharmaceuticals
Suite 201, 697 Burke Road
Camberwell, Victoria 3124

info@islandpharmaceuticals.com

www.islandpharmaceuticals.com

Email Alerts

Which of the following group do you best fit?

 

Follow Us

Follow Us

Site Map Privacy Search
Copyright © Island Pharmaceuticals
Site Map Privacy Search
Site by